What Companies Can Do To Address Prescription Drug Market Manipulation
If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.
YC-backed ReactWise is applying AI to speed up drug manufacturing
Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...
This small-cap pharma firm is eyeing a pie of the growing weight-loss drug market
Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is ...
Bipartisan legislation focuses on prescription drug prices
Bipartisan legislation was reintroduced by Reps. Joe Courtney (D-CT) and Erin Houchin (R-IN), shining light on the prescription drug pricing system to provide fair deals to patients. The bill (320-71) ...
FDA reportedly raids manufacturer of poppers, an increasingly popular party drug
The U.S. Food and Drug Administration has reportedly targeted a manufacturer of poppers, an inhalant drug that has gained ...
The Commonwealth Fund1d
What Pharmacy Benefit Managers Do, and How They Contribute to Drug Spending
Policymakers at the federal and state level have considered a number of reforms, many of which have bipartisan support, to ...
Trump’s HHS Backs Rejection of Drug Discount Plan Rebate Model
The Trump administration is defending a Biden-era decision to reject drug manufacturer plans that would allow them to discount medicines through a rebate rather than up front under a federal drug ...
How pharmaceutical companies are training their workers on AI
Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...
Florida demands patient names, prescriptions from drug middlemen
The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...